Relaxation and crystallization of amorphous carbamazepine studied by terahertz pulsed spectroscopy

Journal of Pharmaceutical Sciences

Volumn 96, Issue 10, 2007, Pages 2703-2709

  Zeitler, J Axel ^a,b,c,d   Taday, Philip F ^c   Pepper, Michael ^b,c   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c TERAVIEW LTD   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amorphous; Carbamazepine; Crystallization; Far infrared; Phase transition; Terahertz pulsed spectroscopy (TPS)

Indexed keywords

CARBAMAZEPINE;

ARTICLE; CRYSTALLIZATION; TEMPERATURE; TERAHERTZ SPECTROSCOPY; VIBRATION;

EID: 35349029298     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20908     Document Type: Article

References (28)

1. Schmuttenmaer CA. 2004. Exploring dynamics in the far-infrared with terahertz spectroscopy. Chem Rev 104:1759-1779.
2. Taday PF, Newnham DA. 2004. Technological advances in terahertz pulsed systems bring far-infrared spectroscopy into the spotlight. Spec Eur 16:20-24.
3. Walther M, Plochocka P, Fischer B, Helm H, Jepsen PU. 2002. Collective vibrational modes in biological molecules investigated by terahertz time-domain spectroscopy. Biopolymers 67:310-313.
4. Walther M, Fischer BM, Jepsen PU. 2003. Noncovalent intermolecular forces in polycrystalline and amorphous saccharides in the far infrared. Chem Phys 288:261-268.
5. Taday PF, Bradley IV, Arnone DD, Pepper M. 2003. Using terahertz pulse spectroscopy to study the crystalline structure of a drug: A case study of the polymorphs of ranitidine hydrochloride. J Pharm Sci 92:831-838.
6. Strachan CJ, Rades T, Newnham DA, Gordon KC, Pepper M, Taday PF. 2004. Using terahertz pulsed spectroscopy to study crystallinity of pharmaceutical materials. Chem Phys Lett 390:20-24.
7. Strachan CJ, Taday PF, Newnham DA, Gordon KC, Zeitler JA, Pepper M, Rades T. 2005. Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and crystallinity. J Pharm Sci 94:837-846.
8. Fischer B, Hoffmann M, Helm H, Modjesch G, Jepsen PU. 2005. Chemical recognition in terahertz time-domain spectroscopy and imaging. Semicond Sci Technol 20:S246-S253.
9. Zeitler JA, Newnham DA, Taday PF, Strachan CJ, Pepper M, Gordon KC, Rades T. 2005. Temperature dependent terahertz pulsed spectroscopy of carbamazepine. Thermochim Acta 436:71-77.
10. Zeitler JA, Kogermann K, Rantanen J, Rades T, Taday PF, Pepper M, Aaltonen J, Strachan CJ. 2006. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy. Int J Pharm-doi:10.1016/j.ijpharm. 2006.1010.1027 (in press).
11. Zeitler JA, Newnham DA, Taday PF, Threlfall TL, Lancaster RW, Berg RW, Strachan CJ, Pepper M, Gordon KC, Rades T. 2006. Characterization of temperature induced phase transitions in the five polymorphic forms of sulfathiazole by terahertz pulsed spectroscopy and differential scanning calorimetry. J Pharm Sci 95:2486-2498.
12. Korter TM, Balu R, Campbell MB, Beard MC, Gregurick SK, Heilweil EJ. 2006. Terahertz spectroscopy of solid serine and cysteine. Chem Phys Lett 418:65-70.
13. Allis DG, Prokhorova DA, Korter TM. 2006. Solid-state modeling of the terahertz spectrum of the high explosive HMX. J Phys Chem A 110:1951-1959.
14. Day GM, Zeitler JA, Jones W, Rades T, Taday PF. 2006. Understanding the influence of polymorphism on phonon spectra: Lattice dynamics calculations and terahertz spectroscopy of carbamazepine. J Phys Chem B 110:447-456.
15. Saito S, Inerbaev TM, Mizuseki H, Igarashi N, Kawazoe Y. 2006. Terahertz vibrational modes of crystalline salicylic acid by numerical model using periodic density functional theory. Jpn J Appl Phys Part 1 - Regul Pap Brief Commun Rev Pap 45:4170-4175.
16. Saito S, Inerbaev TM, Mizuseki H, Igarashi N, Note R, Kawazoe Y. 2006. Terahertz phonon modes of an intermolecular network of hydrogen bonds in an anhydrous beta-D-glucopyranose crystal. Chem Phys Lett 423:439-444.
17. Taraskin SN, Simdyankin SI, Elliott SR, Neilson JR, Lo T. 2006. Universal features of terahertz absorption in disordered materails. Phys Rev Lett 97:055504.
18. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1-12.
19. Craig DQM, Royall PG, Kett VL, Hopton ML. 1999. The relevance of the amorphous state to pharmaceutical dosage forms: Glassy drugs and freeze dried systems. Int J Pharm 179:179-207.
20. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. 2001. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Del Rev 48:91-114.
21. Angell CA, Ngai KL, McKenna GB, McMillan PF, Martin SW. 2000. Relaxation in glassforming liquids and amorphous solids. J Appl Phys 88:3113-3157.
22. Debenedetti PG, Stillinger FH. 2001. Supercooled liquids and the glass transition. Nature 410:259-267.
23. Carpentier L, Decressain R, Desprez S, Descamps M. 2006. Dynamics of the amorphous and crystalline alpha, gamma-phases of indomethacin. J Phys Chem B 110:457-464.
24. Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. 2005. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J Pharm Sci 94:1998-2012.
25. Bates S, Zografi G, Engers D, Morris K, Crowley K, Newman A. 2006. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res 23:2333-2349.
26. Marti E, Kaisersberger E, Kaiser G, Ma W-Y. 2000. Thermoanalytical characterization of pharmaceuticals. 1st edition. Selb, Germany: Netzsch GmbH.
27. Li YH, Han J, Zhang GGZ, Grant DJW, Suryanarayanan R. 2000. In situ dehydration of carbamazepine dihydrate: A novel technique to prepare amorphous anhydrous carbamazepine. Pharm Dev Technol 5:257-266.
28. Chumakov AI, Sergueev I, van Burck U, Schirmacher W, Asthalter T, Ruffer R, Leupold O, Petry W. 2004. Collective nature of the boson peak and universal transboson dynamics of glasses. Phys Rev Lett 92.